FDA’s Jenkins On “Progressive Approval”: Don’t Lower The Efficacy Bar
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Office of New Drugs director says a “weight of the evidence” standard will not provide reasonable assurance of drug efficacy and safety.